MNTK stock forecast, quote, news & analysis
Montauk Renewables Inc is a renewable energy company... Show more
Why Montauk Renewables (MNTK) Stock Is Down -54% in the Last 30 Days
Key Takeaways
- Montauk Renewables shares fell roughly 54% over the 30-day period through mid-November, driven by a late-filing disclosure tied to the company's senior credit facility.
- On November 10, 2026, the company said it could not file its third-quarter Form 10-Q on time because of ongoing lender negotiations and operational delays at its Turkey, North Carolina facility.
- The stock dropped about 57% in a single session on November 10 and declined another 10% the following day, briefly reaching its 52-week low.
- Management expects the delayed financial statements to include a going concern qualification, and several law firms have announced securities-fraud investigations.
- Preliminary third-quarter figures point to higher revenue but significantly lower operating and net income versus the prior-year period.
- For additional detail, explore Montauk Renewables Price Targets, Earnings, and Forecast pages.
- Explore Trending AI Robots to review curated AI trading strategies.
Montauk Renewables (MNTK) Company Overview and Market Position
Montauk Renewables, Inc. (NASDAQ: MNTK) is a Pittsburgh, Pennsylvania-based renewable energy company that recovers and processes biogas from landfills and other non-fossil-fuel sources. The company captures methane that would otherwise be released into the atmosphere and converts it into renewable natural gas (RNG) or electricity for the grid. Operating through two segments — Renewable Natural Gas and Renewable Electricity Generation — Montauk runs projects across California, Idaho, Ohio, Oklahoma, Pennsylvania, North Carolina, and Texas. Its customers include landfill owner-operators, utilities, and refiners, and it monetizes environmental attributes such as renewable identification numbers (RINs). Investors follow the stock for its exposure to the low-carbon fuels theme, balanced against execution and balance-sheet risks.
Montauk Renewables (MNTK) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, MNTK declined approximately 54%, from a closing level of about $2.35 in mid-October to roughly $1.07 by mid-November. The move was concentrated in a two-session collapse in early November rather than a gradual decline.
The last quarter followed a notably volatile path. From the mid-$1.80s in mid-August, the stock rallied sharply into late September and early October, reaching an intraday high above $3, before pulling back and then recovering toward $2.78 in early November. The late-filing disclosure then erased those gains, leaving the stock down roughly 42% versus three months earlier despite its strong mid-period rally.
What Drove MNTK Stock Price in the Last 30 Days
The dominant catalyst was a corporate-governance and financing shock. On November 9, 2026, Montauk announced it would reschedule its third-quarter earnings release and conference call because of a delay in finalizing its Form 10-Q. The following day, the company filed a Form 12b-25 late-filing notice disclosing ongoing negotiations with the lender under its New Senior Credit Facility. The company stated that, in October 2026, it experienced difficulty meeting certain engineering review and operational requirements to place its Turkey, North Carolina facility in service, which affected its ability to draw additional debt.
Montauk is seeking covenant relief, additional borrowing capacity, and temporary forbearance and standstill provisions, and is discussing potential shareholder financing with its board. The company also indicated it expects its financial statements to include a going concern qualification. Preliminary figures showed total operating revenue up about $4.9 million year over year, helped by environmental attribute revenues through its GreenWave joint venture, but operating expenses up about $10.3 million, with operating and net income expected to be significantly lower than a year earlier.
Investors reacted by selling the stock aggressively: shares fell roughly 57% on November 10 and another 10% on November 11, touching a 52-week low. Multiple law firms subsequently announced investigations into potential securities-law violations, adding to the negative sentiment.
What Drove MNTK Stock Performance Over the Last Quarter
The quarter's broader narrative was a sharp reversal. For much of the period, MNTK was in a strong uptrend, more than doubling from its August lows to its September and October peak as investors weighed improving operating results, reaffirmed 2026 guidance, and demand for RNG and associated environmental credits. That optimism gave way to acute balance-sheet and liquidity concerns in early November, when the delayed filing revealed tensions with the company's lender and uncertainty over its ability to fund and complete the Turkey, North Carolina project. The late-quarter collapse underscores how quickly financing and covenant risks can overshadow an otherwise constructive operational story.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of AI-driven trading bots. Tickeron offers hundreds of AI trading bots that collectively trade thousands of tickers, but only the top-performing and most relevant bots appear in this featured section. The bots vary widely in strategy, timeframe, and performance metrics, allowing users to compare approaches that range from short-term technical signals to longer-horizon trend strategies. The page is designed to help traders identify automated strategies that align with their own objectives and risk preferences. For investors monitoring volatile names, reviewing the curated list can offer an additional, data-driven perspective on momentum and market conditions.
MNTK Stock Forecast Drivers: What Investors Should Watch Next
Several factors will shape Montauk's outlook. The most immediate is the filing of its third-quarter Form 10-Q within the extended grace period and the accompanying earnings release and conference call, which should clarify the company's financial position. Investors will also monitor the outcome of lender negotiations, including whether covenant relief and additional borrowing capacity are secured, and whether the company pursues shareholder financing that could be dilutive. Progress on placing the Turkey, North Carolina facility in service, RIN pricing and environmental attribute revenues, and any developments in the securities-fraud investigations are additional watch items. Analyst sentiment has been cautious, with recent ratings near a Hold level. These factors present meaningful execution and liquidity risks that will likely continue to influence the stock.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
MNTK in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 10, 2026
MNTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 32 of 37 cases where MNTK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +15.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNTK advanced for three days, in 221 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 151 of 176 cases where MNTK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MNTK as a result. In 73 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for MNTK turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 46 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
MNTK moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MNTK crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.464) is normal, around the industry mean (2.284). P/E Ratio (54.400) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (1.709) is also within normal values, averaging (48.960).
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. MNTK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ChemicalsSpecialty